Financhill
Buy
55

NOVT Quote, Financials, Valuation and Earnings

Last price:
$135.72
Seasonality move :
13.03%
Day range:
$135.12 - $138.32
52-week range:
$133.17 - $187.12
Dividend yield:
0%
P/E ratio:
76.42x
P/S ratio:
5.18x
P/B ratio:
6.56x
Volume:
224.1K
Avg. volume:
246.4K
1-year change:
-19.48%
Market cap:
$4.9B
Revenue:
$949.2M
EPS (TTM):
$1.78

NOVT Analysts' Consensus Rating

The 3 analysts providing 12-month price projections for Novanta shares anticipate an average target of $161.11, ranging from a low estimate of $138.34 to a high estimate of $185.00. This average target implies a growth of 18.45% compared to the current stock price of $136.02.

Consensus Price Target

$161.11

Highest Price Target

$185.00

Lowest Price Target

$138.34

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 1 1 1

Hold 1 2 2

Sell 0 0 0
Consensus Leans Bullish Hold Hold

NOVT Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Alphabet Stock No Longer a Good Bet?
Is Alphabet Stock No Longer a Good Bet?

Alphabet tripled its price per share over the past 5…

Pepsi Vs Coke Stock: Which Is Best?
Pepsi Vs Coke Stock: Which Is Best?

Coca-Cola (NYSE:KO) and PepsiCo (NYSE:PEP) are two of the largest…

Is CyberArk The Next Big Cybersecurity Stock?
Is CyberArk The Next Big Cybersecurity Stock?

CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Sell
48
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Sell
49
SRPT alert for Mar 19

Sarepta Therapeutics [SRPT] is up 9.33% over the past day.

Sell
46
CVNA alert for Mar 19

Carvana [CVNA] is up 7% over the past day.

Buy
93
ESLT alert for Mar 19

Elbit Systems [ESLT] is up 0.64% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock